Failure to Ensure Proper Medical Supervision for Resident with Hypothyroidism
Summary
The facility failed to ensure the medical care of a resident with hypothyroidism was properly supervised by a physician. The resident, who was admitted to the facility in May 2021 and later to hospice services in March 2024, had abnormal TSH levels indicating a need for medication adjustment. Despite a physician's order for Levothyroxine 175 mcg daily, the resident did not receive the medication from February 7, 2024, to February 21, 2024, missing 15 doses. This lapse was noted in the February 2024 Medication Administration Record (MAR) and confirmed by nursing progress notes and lab results showing elevated TSH levels during this period. Interviews with the resident's PA and the hospice nurse revealed a lack of communication and oversight regarding the resident's TSH levels and medication administration. The PA admitted that medication adjustments were deferred to hospice, and the hospice nurse was unaware of the TSH results, indicating a breakdown in collaboration between the facility and hospice services. The Interim Director of Nursing also acknowledged that the PA should have followed up on lab results and could not explain why the resident missed 15 doses of Levothyroxine. This deficiency highlights a failure in ensuring continuous and coordinated medical care for the resident.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release May 27, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



